BackRepare Therapeutics Overview

Repare Therapeutics Operating Income

Operating Income for RPTX.

Quarterly Operating Income

$1.13M
↓ 103.11% YoY

As of Sep 30, 2025

Annual Operating Income (TTM)

$-78492000.00
↓ 15.66% YoY

Trailing 12 months ending Sep 30, 2025

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin